Masimo Radical® with SET Better than Nellcor N-600 with OxiMax, GE TruSat at Measuring SpO2 during Motion, Low Perfusion June 25, 2012 Masimo (NASDAQ: MASI) announced today a new study in the Journal ...
Masimo Corporation MASI received the FDA’s nod for its RD SET sensors to be used with Masimo Measure-through Motion and Low Perfusion SET pulse oximetry. The procedure is aimed at offering improved ...
Masimo today announced the results of a prospective study published in the International Journal of Neonatal Screening in which researchers in Marrakesh, Morocco, conducted the first Moroccan study on ...
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced Dual SET ® Pulse Oximetry for Root ®, a highly versatile patient monitoring and connectivity hub. The first application ...
The Masimo MX-5 circuit board enables full functionality of Masimo rainbow(R) Pulse CO-Oximetry(TM) measurements at a fraction of the power consumption of prior rainbow(R) boards. Click here for ...
Noting that OSA “can only be reliably diagnosed using multichannel sleep studies, which are expensive, demanding for families and only available in specialist centres,” Dr. Hill and colleagues at the ...
Masimo Corp. ((MASI)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...
Masimo CorporationMASI announced that it has amended its royalty agreement with Nellcor. The agreement was originally inked by the two parties in Jan 2006. Per the amended agreement, Medtronic will ...
Powered by Masimo SET ® pulse oximetry, the Eve CCHD Newborn Screening Application is designed to simplify the CCHD screening process by providing step-by-step visual instructions, animations, and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results